<DOC>
	<DOCNO>NCT02126423</DOCNO>
	<brief_summary>The administration short course topical antibiotic drop and/or intravitreal injection common practice , increase evidence suggests may lower risk infectious endophthalmitis could increase rate antimicrobial resistance . The purpose present study determine antimicrobial resistance profile patient receive numerous ( ≥ 20 ) course antibiotic intravitreal injection compare untreated control . This study compare 20 control patient without prior intravitreal injection 20 patient undergone ≥ 20 prior intravitreal injection accompany course topical antibiotic two day and/or injection procedure . The low , inner eyelid nasal cavity culture evaluated via disk diffusion method antimicrobial sensitivity .</brief_summary>
	<brief_title>Resistance Antibiotics Patients Receiving Eye Injections</brief_title>
	<detailed_description>Before administration anti-VEGF therapy ( Vascular Endothelial Growth Factor ) topical antibiotic , conjunctival nasopharyngeal swab procure Bacti-Swab transport system ( Thermo Fisher Scientific , Waltham , MA ) . For conjunctival sample , sterile swab moisten ophthalmic balanced salt solution gently sweep along low fornix medial lateral canthus , attempt avoid eyelashes eyelid . For nasopharyngeal culture , sterile swab insert 2 cm naris rotate anterior nasal mucosa 3 second . Culture swab plat onto 5 % sheep blood plate incubate 37°C 3 day . Colonies isolate identified API ( Analytical Profile Index ) Microbial Identification Kits ( bioMérieux Inc. , Hazelwood , MO ) . Antibiotic susceptibility determine use Kirby Bauer disc diffusion method . Additional data collect include age , ocular systemic medical condition , number intravitreal injection along anti-VEGF agent use . Statistical calculation antibiotic resistance comprise t-test multivariate analysis .</detailed_description>
	<mesh_term>Macular Degeneration</mesh_term>
	<mesh_term>Diabetic Retinopathy</mesh_term>
	<mesh_term>Retinal Vein Occlusion</mesh_term>
	<mesh_term>Anti-Bacterial Agents</mesh_term>
	<criteria>Adult patient ( age 18 ) diagnose agerelated macular degeneration receive 1st 20th ( &gt; 20th ) intravitreal injection therapy . Those current use topical systemic antibiotic active ocular infection ocular surface disease .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Drug Resistance , Microbial</keyword>
</DOC>